# Endocytosis and Signaling Endosomes

> Taking a receptor into the cell can end its signal or move it to a new place, and where the receptor is sorted decides which. This lesson follows a receptor through a coated pit into the early endosome, where it is sorted back to the surface or on toward the lysosome. Afterwards you will be able to explain why being taken in can end a signal or move it, how Rab GTPases label each compartment, and what happens when a receptor is sorted the wrong way.

Course: Cell Signaling (Space, time and distance). Level: advanced university and graduate. About 12 minutes.
Lesson page (link this one when citing): https://stemhop.com/lessons/endocytosis-and-signaling-endosomes/

Builds on: GTPase Switches: The Timer · Ubiquitin and Regulated Proteolysis as Signals · Receptor Tyrosine Kinases

## What you'll learn

- Explain the two meanings of endocytosis for a signal: ending it by destroying the receptor, and moving it to a platform inside the cell.
- Follow a receptor from the early endosome back to the surface or on to the lysosome, and explain how Rab GTPases give each compartment its identity.
- Describe how a receptor enters the cell through a clathrin-coated pit, what dynamin does, and what other routes exist.
- Predict a receptor's route from its tags and tail sequences, including ubiquitin, and predict what follows when sorting fails.

**Taking a receptor into the cell can end its signal or move it somewhere new, and where the receptor is sorted decides which.** Toll-like receptor 4 is one example: at the plasma membrane it signals through the adaptor MyD88, and after it is taken in it signals through a second adaptor, TRIF, which switches on interferon genes. The traffic behind this is heavy. A macrophage takes in about 3 percent of its surface membrane every minute. It swallows the equivalent of its whole surface about every half hour, and it does not shrink. The membrane must come back as fast as it goes in, and the receptors sitting in that membrane make the trip too, some often and some rarely. So for any receptor you have met in this course, ask where it goes once it is inside the cell, and what the trip does to its signal.

## What’s endocytosis used for?

Endocytosis is the pinching of a patch of plasma membrane inward to make a vesicle, a small closed bag of membrane, that carries in whatever was bound to the patch. It does three jobs.

The first is food. Cholesterol travels in the blood packed into particles of low-density lipoprotein (LDL), which are far too large for any channel or carrier. Michael Brown and Joseph Goldstein found that cells bind LDL to a surface receptor and carry the pair inside, a process that came to be called receptor-mediated endocytosis. Iron enters the same way, bound to the protein transferrin.

The second is membrane upkeep. Secretion adds membrane to the surface and endocytosis takes it back, and worn membrane proteins are pulled in for disposal.

The third is why this lesson sits in a signaling course. For a signal, endocytosis can mean two things. It can end the signal, by taking the receptor off the surface and destroying it. Or it can move the signal, by carrying an active receptor to a new platform inside the cell, where it keeps signaling or signals differently. Which one happens is decided mostly after the receptor is in.

## It all starts with endocytosis: a coat, then a cut

**Film transcript: A Coat, a Reader, and a Cut**

### Film transcript: A Coat, a Reader, and a Cut

Clathrin is a protein shaped like a three-legged pinwheel. Many copies lock together into a curved cage on the inner face of the membrane. Yet clathrin touches neither the membrane nor the cargo. So what does? Adaptor proteins do. The main adaptor at the plasma membrane is AP2. It holds the lipid PIP2, a short sequence in a receptor tail, and clathrin. So a receptor enters a pit because its tail carries a sequence that an adaptor can read. Brown and Goldstein met the proof in a patient known as J.D. This patient's LDL receptors could bind LDL. But they stayed scattered over the surface instead of gathering in pits, and the cells could not take LDL in.

The fault was later traced to one tyrosine in the receptor's tail, replaced by cysteine. A pit deepens until it hangs from the surface by a thin neck. Dynamin, a large GTPase, assembles into a collar around the neck. When it hydrolyzes GTP, the neck is cut. The coat is then stripped off, and the bare vesicle can fuse with its target.

The best understood way in is the clathrin-coated pit. Clathrin is a protein shaped like a three-legged pinwheel, and many copies lock together into a curved cage on the inner face of the membrane. Clathrin touches neither the membrane nor the cargo. Adaptor proteins do that. The main adaptor at the plasma membrane, AP2, holds the lipid phosphatidylinositol 4,5-bisphosphate (PIP2) (an address from the lesson on lipid anchors), short sequences in receptor tails, and clathrin. So a receptor enters a pit when its cytoplasmic tail carries a sequence that an adaptor can read, or when it binds a protein, such as arrestin, that links it to the coat.

Brown and Goldstein met the proof in a patient known as J.D. This patient’s low-density lipoprotein (LDL) receptors could bind LDL but stayed scattered over the surface instead of gathering in pits, and the cells could not take LDL in. The fault was later traced to one tyrosine in the receptor’s tail, replaced by cysteine.

A pit deepens until it hangs from the surface by a thin neck. Dynamin, a large GTPase, assembles into a collar around the neck, and when it hydrolyzes GTP the neck is cut. The coat is then stripped off and the bare vesicle can fuse with its target.

There are other doors. Caveolae are small flask-shaped pits built around a protein called caveolin, macropinocytosis gulps large volumes of fluid, and several more routes that need no clathrin have been described and are less well mapped.

**A receptor’s signaling can influence which internalization pathway it takes.** How hard a receptor is signaling can change how it enters and where it ends up. The best-studied case, the epidermal growth factor (EGF) receptor, is under Going deeper.

## The early endosome is a sorting station

The early endosome is the first stop for almost all endocytosed cargo. It lies near the plasma membrane, and it sorts cargo into separate patches of its own membrane that set the cargo’s fate: back to the surface, back to the Golgi, or on to the lysosome to be destroyed.

Two physical features do much of the sorting. One is acid. A proton pump in the endosome membrane holds the inside at about pH 6 to 6.5, and at that pH many ligands let go. Low-density lipoprotein (LDL) falls off its receptor, and iron falls off transferrin. The other is shape. An early endosome has a round body with thin tubes growing out of it. A tube is nearly all membrane and almost no volume, so membrane proteins spread into the tubes while dissolved contents stay in the body. The tubes pinch off and go back to the surface, so a receptor with no other instruction mostly goes back too.

There is a fast way back, taking a few minutes, straight from tubes rich in the protein Rab4. There is a slow way, taking tens of minutes, that passes through a second compartment and uses Rab4 and Rab11. An LDL receptor makes the round trip about every ten minutes, again and again.

**Rab proteins define and drive the maturation state.** Rabs are small GTPase switches of the kind in the lesson on GTPase switches: on with GTP, off with GDP, flipped by guanine-nucleotide exchange factors (GEFs) and GAPs. Human cells have more than sixty, and most mark a particular compartment, a domain within one, or a step of traffic. Rab5 marks the early endosome. In its GTP form it sits on the membrane and recruits effectors, proteins that bind only the on state, which tether incoming vesicles and help them fuse.

A Rab’s lipid tail would stick to any membrane, so cells keep GDP-bound Rabs soluble with a protein called GDI, and later work points to a Rab’s own GEF as a main part of its address, since a Rab is switched on, and so held, on the membrane where its GEF sits. The details are under Going deeper.

## Headed to the lysosome: the receptor is sealed inside

A receptor leaves the default route when it carries a tag, and the tag is one you know: ubiquitin. For an active epidermal growth factor (EGF) receptor the ligase Cbl adds it, as the lesson on receptor tyrosine kinases describes. This ubiquitin is not read by the proteasome. A set of proteins on the endosome called ESCRT binds it, gathers tagged receptors into a patch, and pushes the patch inward until it pinches off as a small vesicle inside the endosome. An endosome filled with such vesicles is a multivesicular endosome (MVE), also called a multivesicular body.

What is the purpose of MVEs? Think about which way the receptor faces. On the outer membrane of an endosome, the receptor’s tail still points into the cytosol and can still reach its partners. On an internal vesicle, the tail is sealed inside and cannot reach the cytosol at all. That step ends the signal before anything is destroyed. It also puts the whole receptor where the lysosome’s enzymes can reach it.

Meanwhile the compartment itself changes. Marino Zerial’s laboratory filmed single endosomes in living cells and saw Rab5 leave as Rab7 arrived, which they called Rab conversion. With Rab7 come new effectors, stronger acid (about pH 5.5 in late endosomes) and a growing load of internal vesicles. The late endosome then fuses with a lysosome, a bag of digestive enzymes at about pH 4.5 to 5, and the receptor is broken down.

*Figure (AI-generated illustration).* An endosome stays the same compartment but changes identity: Rab5 leaves and Rab7 arrives, the lumen grows more acid (about pH 5.5 in late endosomes) and fills with internal vesicles, and the late endosome fuses with a lysosome (pH 4.5 to 5), where the receptor is broken down. Receptor symbols are schematic. Image: a three-panel strip. Panel 1, an early endosome marked Rab5 with tubular extensions and a lumen at pH 6 to 6.5. Panel 2, Rab conversion: the endosome now carries Rab7, has a lumen at about pH 5.5, and holds inner vesicles that contain receptors. Panel 3, the late endosome, packed with inner vesicles, fuses with a lysosome at pH 4.5 to 5, where the receptor is broken down.

## A receptor that keeps talking, and one that escapes

Between the coated pit and the internal vesicle, a receptor spends time on the outer membrane of an endosome with its tail in the cytosol. Is it still signaling? In 1996 Sandra Schmid’s laboratory tested this by blocking endocytosis in HeLa cells with a dynamin mutant defective in GTP binding and hydrolysis. If endocytosis only ended signals, every response to epidermal growth factor (EGF) should have gone up. The cells did divide more, but some responses fell, including full activation of the MAP kinase extracellular signal-regulated kinase (ERK). On this evidence part of the EGF signal needs the receptor to be inside, although later experiments that blocked endocytosis in other ways did not all find the same fall in ERK.

Other receptors change what they say when they move. Toll-like receptor 4 signals through the adaptor MyD88 at the plasma membrane. After it is taken in, it signals through a second adaptor, TRIF, which switches on interferon genes. The Toll-like receptors that detect nucleic acids, such as TLR3, TLR7 and TLR9, work only in endosomes, where the remains of digested microbes arrive. And some G-protein-coupled receptors, taken in with arrestin as the lesson on turning signals off describes, go on activating G proteins from endosomes.

Now break the sorting. In roughly 3 percent of non-small-cell lung cancers, a splicing error removes exon 14 from the messenger RNA for MET, a receptor tyrosine kinase. The missing stretch holds tyrosine 1003, the docking site for Cbl. The receptor is poorly tagged with ubiquitin, escapes the lysosome and keeps signaling for longer than it should. The fault is not an overactive kinase. It is a receptor that misses its turn to the lysosome. Two MET kinase inhibitors, capmatinib and tepotinib, are approved for lung cancers with this change.

A neuron poses the hardest version of the keep-talking problem, because its endosomes must carry a signal the length of an axon. That is the next lesson.

### Design problem

Two receptors on the same cell bind their ligands at the same moment. One must signal for about ten minutes and then be silent for hours. The other must keep signaling for hours. Using only the sorting decisions made at the early endosome, design the difference. Say what tag or sequence each receptor would need.

> **One way to do it.** Give the brief receptor a docking site for a ubiquitin ligase that appears only when the receptor is active, for example a tyrosine the receptor phosphorylates on its own tail, plus lysines for the ligase to tag. Give it a ligand that stays bound at pH 6, so the receptor stays active and tagged all the way in. ESCRT then seals it inside internal vesicles and the signal stops. The silence lasts for hours because the cell has to make new receptors to replace the ones it destroyed.
>
> Give the lasting receptor no ligase site, so it is never tagged, and a ligand that falls off at pH 6. It takes the tubes back to the surface in minutes, empty and ready to bind again, and it keeps signaling for as long as ligand is outside. To make the return more certain, add a tail sequence that recycling machinery reads. The β2-adrenergic receptor has one at its very end, a sequence that binds PDZ domains.
>
> Cells do use this logic. The EGF receptor has two ligands with different fates. EGF tends to stay bound in the endosome and takes the receptor to the lysosome, while transforming growth factor alpha lets go in the acid and the receptor recycles.

## Going deeper

### How a Rab finds its membrane

How does a Rab find its membrane? Most Rabs carry one or two geranylgeranyl groups, 20-carbon lipids, on their tail, and a greasy tail would stick to any membrane it met. Suzanne Pfeffer’s laboratory worked on this with Rab9. A protein called GDI wraps the GDP-bound Rab and hides the tail, so the Rab stays dissolved in the cytosol. Her group found an activity on endosome membranes, a displacement factor, that frees the Rab from GDI, and showed that GDP is exchanged for GTP once the Rab reaches the membrane. Later work points to the Rab’s own guanine-nucleotide exchange factor (GEF) as a main part of the address: a Rab is switched on, and so held, on the membrane where its GEF sits. GDI does not pull off the GTP form, so the Rab stays put until a GAP switches it off.

*Figure (AI-generated illustration).* GDI keeps GDP-bound Rab soluble by hiding its lipid tail. A membrane displacement factor helps release it, and a membrane GEF then swaps GDP for GTP, helping fix where Rab is active. Active Rab recruits effectors until a GAP switches it off. The GEF is not drawn. Image: a loop showing a GDP-bound Rab held in the cytosol by GDI, freed at an endosome membrane by a displacement factor, switched to GTP (by a membrane GEF, not drawn) and bound by an effector, then switched off by a GAP.

### A lipid of late endosomes

In late endosomes, the internal vesicles are rich in an unusual lipid, lysobisphosphatidic acid, which is scarce in early endosomes.

### Dose and route for the EGF receptor

The best studied case is the epidermal growth factor (EGF) receptor. In HeLa cells, Sara Sigismund, Pier Paolo Di Fiore and their colleagues reported that at low doses of EGF the receptor enters almost entirely through coated pits and is mostly recycled. At high doses the receptor also becomes tagged with ubiquitin, and a share of it enters by a route without clathrin and is mostly destroyed. Treat that as a result in one cell line, since other laboratories find clathrin carrying most of the receptor at high doses too. The modest version is safe: how hard a receptor is signaling can change how it enters and where it ends up.

---

From STEMhop (https://stemhop.com), free lessons by Christopher Deppmann. Lesson text © the authors. Practice questions: https://stemhop.com/lessons/endocytosis-and-signaling-endosomes/
